MBRX

Moleculin Biotech, Inc. Common Stock

$2.01 +$0.11 +5.47%


Own 3 of MBRX at $1.79 which is 0.01% of the portfolio.

+$0.22 (+12.29%)

Shares Bought7
Shares Sold4
Total11
Shares Owned3
Last Price$2.01
Total Return$1.45
Range Today$1.90 - $2.02
52 Week Range$0.71 - $3.75
Open$1.91
Market Cap$39.56M
Volume/Average626.77K/1.24M
P/E Ratio-
Dividend/Yield-




Moleculin Biotech, Inc. is a preclinical stage pharmaceutical company, which focuses on the development of anti-cancer drug candidates. Its Annamycin product candidate helps in the treatment of relapsed or refractory acute myeloid leukemia. The company's preclinical small molecule portfolios focus on the modulation of hard-to-target tumor cell signaling mechanisms; and the metabolism of tumors. Moleculin Biotech was founded by Walter V. Klemp, Donald H. Picker and Waldemar Priebe in July 2015 and is headquartered in Houston, TX.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners
17-12-18 18:14 $1.70 $2.01 +$0.31 +18.58% itsrickyftw
18-01-22 16:49 $1.85 $2.01 +$0.16 +8.65% sunsuhan
17-12-18 18:16 $1.70 $2.01 +$0.31 +18.58% itsrickyftw

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
18-01-02 18:50 18-01-03 14:06 $1.81 $1.83 +$0.02 +0.83% playerk125
17-08-01 19:49 17-08-03 13:22 $2.68 $2.92 +$0.24 +8.96%
18-01-02 18:44 18-01-03 14:05 $1.81 $1.83 +$0.02 +0.83% playerk125
17-08-01 19:52 17-08-03 14:18 $2.54 $2.93 +$0.39 +15.36% h3ll0j3ll0 killermagikarp manthello dwarvesthinkgeek